PAVS in Cardiology

Phase 1

Completed

Interventions: Behavioral: Physical activity assessment, promotion and monitoring in a preventive cardiology clinic

Brief Summary: Brief Summary This is a pilot study implemented physical activity assessment, promotion and monitoring in patients. Patients will be assessed by the physical activity vital sign (PAVS) during check-in for their appointment. During their visit with the cardiologist, a clinical decision support tool will alert the cardiologist to patients achieving low (\<50% of recommended) physical activity. The cardiologist may refer the patient to cardiac rehabilitation if appropriate and/or counsel them to increase their physical activity levels. The patients may opt to enroll in the monitoring phase of the study. They will be given a Fitbit pedometer and their Fitbit account can sync to their MyChart account. After that sync, the patients step counts will be available for their cardiologists to review as needed.

Recruitment & Eligibility

Inclusion Criteria

Adult patients in the Center who are age 18 and above will be assessed with the PAVS as part of routine care. To enroll in the home monitoring of PA:

Patients must achieve < 50% of PA recommendations according to PAVS screening questions
Have a cellular phone with data plan or a computer to sync Fitbit data
Speak English or Spanish
Be willing to wear a Fitbit Zip for 3 months

Exclusion Criteria

Adults with a physical disability or medical diagnosis limiting their ability to exercise (e.g. wheelchair bound, aortic stenosis, unstable angina)
Planned surgery within three months
Those with decisional incapacity therefore unable to comply with study requirements (i.e. related to cognitive deficits or psychiatric diagnosis)
Pregnant or breastfeeding women.

Arm && Interventions

Group	Intervention	Description
Participants with cardiovascular disease or cardiovascular disease risk factors	Physical activity assessment, promotion and monitoring in a preventive cardiology clinic	Population We will recruit 59 males and females age \> 18 being seen in the NYU Langone Center for Prevention of Cardiovascular Disease (4F). Participants have cardiovascular disease or cardiovascular disease risk factors.

Primary Outcome Measures

Name	Time	Method
Waist Circumference	Month 3	Waist Circumference will be measured to the nearest inch using standard technique
Blood Lipid Levels	Month 3	Total cholesterol, HDL, and triglycerides will be measured by CLIA-waived Alere Cholestech LDX® Analyzer which is certified by the Center for Disease Control's Lipid Standardization Program and Cholesterol Reference Method Laboratory Method Network. This will be measured by a single fingerstick using standard aseptic technique.
Step Counts	Month 3	Pedometer
BMI	Month 3	BMI will be calculated by height and weight measured at the time of the Center visit on a balance beam scale.
Blood Pressure	Month 3	Blood pressure (BP) will be measured in right arm (unless contraindicated) after sitting for 5 minutes and repeated after a 5-minute interval. Both will be recorded and the average used in analyses.
Framingham Heart Study Risk Score	Month 3	The Framingham Heart Study Risk Score (10-year risk) will be calculated using the appropriate risk model based on participants' age, gender, diabetes status and prior coronary heart disease. Risk is considered low if the FRS is less than 10%, moderate if it is 10% to 19%, and high if it is 20% or higher.